Drug Shortage Report for RAN-ROPINIROLE
Report ID | 158553 |
Drug Identification Number | 02314037 |
Brand name | RAN-ROPINIROLE |
Common or Proper name | ROPINIROLE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ROPINIROLE |
Strength(s) | 0.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N04BC |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-07-06 |
Actual start date | 2022-09-09 |
Estimated end date | 2023-10-15 |
Actual end date | 2024-04-13 |
Shortage status | Resolved |
Updated date | 2024-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.